We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Clavis Pharma Announces Successful Investigational New Drug Application Review for Intravenous CP-4126

Company receives the FDA clearance to include patients in the USA in its phase II clinical programme for Intravenous CP-4126.
News

CombinatoRx and Neuromed Sign Merger Agreement

Merger to create a sustainable biotechnology company, bringing together the product assets, discovery capabilities and financial resources.
News

Glutamic Acid Linked to Lower Blood Pressure

The new research suggests that glutamic acid may be one of the components of vegetable protein linked to lower blood pressure.
News

Increased Demand Drives Queensland Compound Library Expansion

QCL capacity is increased by the acquisition of an additional comPOUND® storage module.
News

Issues in the Design of Clinical Trials of Antimycobacterial Drugs for Treating Tuberculosis

FDA to host a public workshop to review scientific issues in clinical trial design for treating tuberculosis.
News

MorphoSys Secures Full-Term of Strategic Alliance

Novartis has committed to a ten-year term of the strategic alliance originally signed in December 2007.
News

Optimata to Collaborate with Teva Pharmaceutical on Clinical Development of Solid Tumor Cancer Drugs

The agreement is intended to rescue and redirect the clinical development of discontinued drug candidates.
News

Imaging Technique Allows Researchers to Monitor Protein Changes in Mouse Tumors

The technique monitors the HER2 protein found in above-normal amounts in breast, ovarian, prostate and lung cancers.
News

MorphoSys and the University of Melbourne File new Patent Applications in MOR103 Program

MOR103 HuCAL antibody against human GM-CSF is currently in development for the treatment of rheumatoid arthritis.
News

New Biomarker Method Could Increase the Number of Diagnostic Tests for Cancer

Researchers develop a potential method to increase accuracy in detecting real cancer biomarkers that is highly reproducible across laboratories.
Advertisement